Postmarketing Safety Profile of Subcutaneous Interferon Beta-1a Given 3 Times Weekly: A Retrospective Administrative Claims Analysis. Smith MY, Sabidó-Espin M, Trochanov A, Samuelson M, Guedes S, Corvino FA, Richy FF J Manag Care Spec Pharm. 2015 Aug; 21(8):650-60. PMID: 26233537. Abstract CommentRecommendBookmarkWatch